TrialDiabetologia2004
Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes.
J I Davies et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
35 papers cite it
this paperpooled ittrialcites it
TrialDiabetologia2004
J I Davies et al.PubMed ↗Publisher ↗
No numbers read from the abstract.